Drugs being explicitly developed to treat rare diseases are getting more expensive. An analysis by Reuters found that prices ...

Australia just approved the first new Alzheimer’s treatment in decades. But before patients get their hopes up, there’s a ...

Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...

Entrepreneur Mark Cuban's Cost Plus ... A New RNA-Based Drug Startup Launches With Rutgers Science A Philadelphia-based biotech startup — by way of Rutgers University in New Jersey — has raised an ...

Biotechs have faced several challenging years with slumping valuations and a competitive funding environment. However, the latest slew of ...

President Donald Trump's claim that prescription drug prices will be reduced “almost immediately" under a new executive order is misleading.

Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

If the goals of his executive order are achieved, price reductions would not happen “almost immediately,” experts say.

Published studies have used periods ranging from 4 to 12 years ... The price of innovation: new estimates of drug development costs. J. Health Econ. 22, 151–185 (2003). Article Google Scholar ...

It’s also received a “Fast Track” designation from the FDA, which will speed up the drug development process. There’s also ongoing work on a potential HIV vaccine. To find out more about ...